受强制性开放获取政策约束的文章 - Sylvie Retout了解详情
无法在其他位置公开访问的文章：1 篇
cLRT‐Mod: An efficient methodology for pharmacometric model‐based analysis of longitudinal Phase II dose finding studies under model uncertainty
S Buatois, S Ueckert, N Frey, S Retout, F Mentré
Statistics in Medicine 40 (10), 2435-2451, 2021
强制性开放获取政策： National Institute of Health and Medical Research, France
可在其他位置公开访问的文章：3 篇
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
S Ostrowitzki, RA Lasser, E Dorflinger, P Scheltens, F Barkhof, ...
Alzheimer's research & therapy 9, 1-15, 2017
强制性开放获取政策： National Institute for Health Research, UK
Modeling Alzheimer's disease progression using disease onset time and disease trajectory concepts applied to CDR‐SOB scores from ADNI
I Delor, JE Charoin, R Gieschke, S Retout, P Jacqmin, ...
CPT: pharmacometrics & systems pharmacology 2 (10), 1-10, 2013
强制性开放获取政策： US National Institutes of Health, Canadian Institutes of Health Research
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s
S Ostrowitzki, RA Lasser, E Dorflinger, P Scheltens, F Barkhof, ...
强制性开放获取政策： National Institute for Health Research, UK
出版信息和资助信息由计算机程序自动确定